Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

1.

Low-dose aspirin does not prevent thrombovascular accidents in low-risk haemodialysis patients during treatment with recombinant human erythropoietin.

Kooistra MP, van Es A, Marx JJ, Hertsig ML, Struyvenberg A.

Nephrol Dial Transplant. 1994;9(8):1115-20.

PMID:
7800210
[PubMed - indexed for MEDLINE]
2.

Does additional treatment with fish oil mitigate the side effects of recombinant human erythropoietin in dialysis patients?

de Fijter CW, Popp-Snijders C, Oe LP, Tran DD, van der Meulen J, Donker AJ.

Haematologica. 1995 Jul-Aug;80(4):332-4.

PMID:
7590502
[PubMed - indexed for MEDLINE]
Free Article
3.

Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.

Wizemann V, Rutkowski B, Baldamus C, Scigalla P, Koytchev R; Epoetin Zeta Study Group.

Curr Med Res Opin. 2008 Mar;24(3):625-37. doi: 10.1185/030079908X273264. Erratum in: Curr Med Res Opin. 2008 Oct;24(10):3007. Curr Med Res Opin. 2008 Apr;24(4):1155.

PMID:
18208642
[PubMed - indexed for MEDLINE]
4.

Effect of human recombinant erythropoietin on bleeding time, platelet number and function in children with end-stage renal disease maintained by haemodialysis.

Fabris F, Cordiano I, Randi ML, Casonato A, Montini G, Zacchello G, Girolami A.

Pediatr Nephrol. 1991 Mar;5(2):225-8.

PMID:
2031840
[PubMed - indexed for MEDLINE]
5.

The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.

Silverberg DS, Blum M, Agbaria Z, Deutsch V, Irony M, Schwartz D, Baruch R, Yachnin T, Steinbruch S, Iaina A.

Clin Nephrol. 2001 Mar;55(3):212-9.

PMID:
11316241
[PubMed - indexed for MEDLINE]
6.

The haemodynamic effects of correction of anaemia in haemodialysis patients using recombinant human erythropoietin.

Abdulhadi MH, Fouad-Tarazi FM, Thomas T, Bravo EL, Paganini EP.

Nephrol Dial Transplant. 1990;5 Suppl 1:102-8.

PMID:
2129437
[PubMed - indexed for MEDLINE]
7.

Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients.

Goicoechea M, Vazquez MI, Ruiz MA, Gomez-Campdera F, Perez-García R, Valderrábano F.

Nephron. 1998;78(1):23-7.

PMID:
9453399
[PubMed - indexed for MEDLINE]
8.

Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy.

Case DC Jr, Bukowski RM, Carey RW, Fishkin EH, Henry DH, Jacobson RJ, Jones SE, Keller AM, Kugler JW, Nichols CR, et al.

J Natl Cancer Inst. 1993 May 19;85(10):801-6.

PMID:
8487324
[PubMed - indexed for MEDLINE]
9.

The haematopoietic effect of recombinant human erythropoietin in haemodialysis is independent of the mode of administration (i.v. or s.c.).

De Schoenmakere G, Lameire N, Dhondt A, Van Loo A, Van der Goten J, Duym P, Vanholder R.

Nephrol Dial Transplant. 1998 Jul;13(7):1770-5.

PMID:
9681726
[PubMed - indexed for MEDLINE]
Free Article
10.

Increase in mean platelet volume in patients with chronic renal failure treated with erythropoietin.

Sharpe PC, Desai ZR, Morris TC.

J Clin Pathol. 1994 Feb;47(2):159-61.

PMID:
8132831
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

National Cooperative rHu Erythropoietin Study in patients with chronic renal failure--an interim report. The National Cooperative rHu Erythropoietin Study Group.

Levin NW, Lazarus JM, Nissenson AR.

Am J Kidney Dis. 1993 Aug;22(2 Suppl 1):3-12.

PMID:
8352269
[PubMed - indexed for MEDLINE]
12.
13.

Effects of recombinant human erythropoietin on cerebral and cutaneous blood flow and on blood coagulability.

Johnson WJ, McCarthy JT, Yanagihara T, Osmundson PJ, Ilstrup DM, Jenson BM, Bowie EJ.

Kidney Int. 1990 Nov;38(5):919-24.

PMID:
2266676
[PubMed - indexed for MEDLINE]
14.

Anemia and carnitine supplementation in hemodialyzed patients.

Kletzmayr J, Mayer G, Legenstein E, Heinz-Peer G, Leitha T, Hörl WH, Kovarik J.

Kidney Int Suppl. 1999 Mar;69:S93-106.

PMID:
10084293
[PubMed - indexed for MEDLINE]
15.

[The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].

Stojimirović B, Grujić-Adanja G.

Srp Arh Celok Lek. 1997 May-Jun;125(5-6):163-7. Serbian.

PMID:
9265238
[PubMed - indexed for MEDLINE]
16.

Does the use of erythropoietin in hemodialysis patients increase dialysis graft thrombosis rates?

Standage BA, Schuman ES, Ackerman D, Gross GF, Ragsdale JW.

Am J Surg. 1993 May;165(5):650-4.

PMID:
8488954
[PubMed - indexed for MEDLINE]
17.

Correction of anaemia in haemodialysis patients with recombinant human erythropoietin.

Boran M, Dalva I, Yazicioğlu A, Akbay E, Cetin S.

Int Urol Nephrol. 1993;25(2):197-203.

PMID:
8365853
[PubMed - indexed for MEDLINE]
18.

Effect of recombinant human erythropoietin on platelet production in dialysis patients.

Kaupke CJ, Butler GC, Vaziri ND.

J Am Soc Nephrol. 1993 Apr;3(10):1672-9.

PMID:
8318683
[PubMed - indexed for MEDLINE]
Free Article
19.
20.

Is erythropoietin a survival factor for red blood cells?

Polenakovic M, Sikole A.

J Am Soc Nephrol. 1996 Aug;7(8):1178-82.

PMID:
8866410
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk